| Net income |
-373.37M |
| Depreciation |
308.32M |
| Amortization of intangible assets |
| Stock-based compensation expense, net |
376.64M |
| Non-cash restructuring charges |
| Tax benefits from stock-based awards |
| Excess tax benefits from stock-based awards |
-1.74M |
| Deferred income taxes |
-175.98M |
| Earnings in equity interests |
-249.58M |
| Dividends received from equity investee |
156.97M |
| (Gain) loss from sales of investments, assets, and other, net |
| Accounts receivable, net |
106.26M |
| Prepaid expenses and other |
346.1M |
| Accounts payable |
-10.08M |
| Accrued expenses and other liabilities |
12.97M |
| Deferred revenue |
-9.99M |
| Net cash provided by operating activities |
| Acquisition of property and equipment, net |
-197.51M |
| Purchases of marketable debt securities |
| Proceeds from sales of marketable debt securities |
| Proceeds from maturities of marketable debt securities |
4.22B |
| Acquisitions, net of cash acquired |
| Purchases of intangible assets |
-2M |
| Proceeds from the sale of a divested business |
| Other investing activities, net |
-127K |
| Net cash provided (used in) by investing activities |
| Proceeds from issuance of common stock, net |
15.51M |
| Repurchases of common stock |
0 |
| Excess tax benefits from stock-based awards |
1.74M |
| Tax withholdings related to net share settlements of restricted stock awards and restricted stock units |
-157.44M |
| Other financing activities, net |
-10.41M |
| Net cash used in financing activities |
| Effect of exchange rate changes on cash and cash equivalents |
34.56M |
| Net change in cash and cash equivalents |
-220.6M |
| Cash and cash equivalents at beginning of period |
1.63B |
| Cash and cash equivalents at end of period |
1.41B |
